| Title |
Frequency of Adverse Events in the Placebo Arms of COVID-19 Vaccine Trials
|
|---|---|
| Published in |
JAMA Network Open, January 2022
|
| DOI | 10.1001/jamanetworkopen.2021.43955 |
| Pubmed ID | |
| Authors |
Julia W. Haas, Friederike L. Bender, Sarah Ballou, John M. Kelley, Marcel Wilhelm, Franklin G. Miller, Winfried Rief, Ted J. Kaptchuk |
X Demographics
The data shown below were collected from the profiles of 2,506 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 251 | 10% |
| Japan | 160 | 6% |
| United Kingdom | 101 | 4% |
| Canada | 73 | 3% |
| Spain | 52 | 2% |
| Germany | 51 | 2% |
| France | 50 | 2% |
| Korea, Republic of | 24 | <1% |
| Australia | 23 | <1% |
| Other | 291 | 12% |
| Unknown | 1430 | 57% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2151 | 86% |
| Scientists | 200 | 8% |
| Practitioners (doctors, other healthcare professionals) | 120 | 5% |
| Science communicators (journalists, bloggers, editors) | 31 | 1% |
| Unknown | 4 | <1% |
Mendeley readers
The data shown below were compiled from readership statistics for 161 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 161 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 27 | 17% |
| Student > Master | 14 | 9% |
| Other | 13 | 8% |
| Student > Bachelor | 12 | 7% |
| Student > Ph. D. Student | 10 | 6% |
| Other | 28 | 17% |
| Unknown | 57 | 35% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 31 | 19% |
| Psychology | 14 | 9% |
| Nursing and Health Professions | 9 | 6% |
| Neuroscience | 9 | 6% |
| Agricultural and Biological Sciences | 6 | 4% |
| Other | 28 | 17% |
| Unknown | 64 | 40% |
Attention Score in Context
This research output has an Altmetric Attention Score of 3173. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 April 2024.
All research outputs
#2,013
of 25,791,495 outputs
Outputs from JAMA Network Open
#23
of 9,936 outputs
Outputs of similar age
#115
of 520,438 outputs
Outputs of similar age from JAMA Network Open
#2
of 513 outputs
Altmetric has tracked 25,791,495 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 9,936 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 128.4. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 520,438 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 513 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.